Stockscreener 앱 받기
10.17
1.90%
0.19
Iteos Therapeutics Inc 주식(ITOS)의 최신 뉴스
ITeos Therapeutics Insider Sold Shares Worth $1,048,264, According to a Recent SEC Filing - marketscreener.com
Bank of America Corp DE Decreases Position in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Brokerages Set iTeos Therapeutics, Inc. (NASDAQ:ITOS) PT at $15.86 - Defense World
Layoff Tracker: National Resilience Closes 60% of Its Manufacturing Footprint - BioSpace
ITeos Therapeutics Insider Sold Shares Worth $1,592,520, According to a Recent SEC Filing - marketscreener.com
Director David Hallal Sells 114,682 Shares of ITeos Therapeutics Inc (ITOS) - GuruFocus
Squarepoint Ops LLC Sells 18,686 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
iTeos Therapeutics CEO Michel Detheux sells $1.59m in stock By Investing.com - Investing.com India
iTeos Therapeutics CEO Michel Detheux sells $1.59m in stock - Investing.com
iTeos Therapeutics Executives Sell Significant Shares - TradingView
Nuveen Asset Management LLC Trims Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
iteos therapeutics announces board resignation - Investing.com
iteos therapeutics announces board resignation By Investing.com - Investing.com UK
Tim Van Hauwermeiren Resigns from iTeos Board - TipRanks
Deutsche Bank AG Sells 14,418 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
More bad news in biotech: Watertown cancer firm iTeos shutting down - The Boston Globe
Long Term Trading Analysis for (ITOS) - news.stocktradersdaily.com
Q2 EPS Forecast for iTeos Therapeutics Decreased by Analyst - Defense World
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Position Increased by Ameriprise Financial Inc. - Defense World
iTeos Therapeutics (ITOS) Upgraded to Buy: Here's What You Should Know - MSN
Wedbush Lowers Earnings Estimates for iTeos Therapeutics - Defense World
Rx Rundown: Novartis, iTeos Therapeutics, Moderna and more - Medical Marketing and Media
iTeos Therapeutics Stock Jumps Following Operational Closure Announcement - MSN
All Over For iTeos But Applause For Plan To Return Cash Fast - insights.citeline.com
iTeos to shut down operations after TIGIT setback and GSK exit - The Pharma Letter
iTeos Therapeutics (NASDAQ:ITOS) Receives “Equal Weight” Rating from Wells Fargo & Company - Defense World
iTeos Therapeutics to wind down operations, explore asset sales By Investing.com - Investing.com South Africa
iTeos Therapeutics (NASDAQ:ITOS) Lowered to “Neutral” Rating by Wedbush - Defense World
Wedbush cuts iTeos stock rating, raises PT to $12 from $10 - Investing.com Canada
Drug developer iTeos to shut down operations after cancer therapy setback - 1470 & 100.3 WMBD
Cancer drugmaker iTeos to shut down - BioPharma Dive
iTeos Therapeutics To Wind Down Operations, Explores Asset Sale: Retail Believes It’s ‘Worth More Selling It Off’ - Investing.com India
iTeos Therapeutics stock surges on wind-down news By Investing.com - Investing.com Canada
Watertown immuno-oncology biotech winds down operations - The Business Journals
iTeos Therapeutics (ITOS) Downgraded by Wells Fargo with Revised Price Target | ITOS Stock News - GuruFocus
iTeos Therapeutics (ITOS) Faces Downgrade Amid Operational Changes | ITOS Stock News - GuruFocus
ITeos Therapeutics (ITOS) Sees Downgrade and Target Price Cut | - GuruFocus
ITeos Therapeutics (ITOS) Sees Downgrade and Target Price Cut | ITOS Stock News - GuruFocus
iTeos Therapeutics stock surges on wind-down news - Investing.com
ITeos Therapeutics (ITOS) Receives Analyst Downgrade from Wedbus - GuruFocus
iTeos Therapeutics (ITOS) Downgraded as Company Plans Operationa - GuruFocus
Wedbush Downgrades iTeos Therapeutics (ITOS) Rating to Neutral | - GuruFocus
I Teos Therapeutics Inc Expected Severance Costs Of $21.8 Million To $24.7 Million - marketscreener.com
ITeos Therapeutics (ITOS) Receives Analyst Downgrade from Wedbush | ITOS Stock News - GuruFocus
Wedbush Downgrades iTeos Therapeutics to Neutral From Outperform, Adjusts Price Target to $12 From $10 - marketscreener.com
iTeos Therapeutics (ITOS) to Cease Operations and Explore Strate - GuruFocus
iTeos Therapeutics (ITOS) Shares Surge on Plans to Cease Operati - GuruFocus
iTeos Therapeutics (ITOS) to Wind Down Operations, Focus on Shar - GuruFocus
Drug developer iTeos winds down after cancer therapy setback - marketscreener.com
iTeos Therapeutics (ITOS) to Wind Down Operations, Focus on Shareholder Value | ITOS Stock News - GuruFocus
iTeos Therapeutics Announces Strategic Wind Down Plan - TipRanks
ITeos Therapeutics to Wind Down Operations - marketscreener.com
iTeos Therapeutics to wind down operations, explore asset sales - Investing.com Australia
1.91%
1.17%
자본화:
|
볼륨(24시간):